Welcome to Multibagg AI
Log in to access personalized features
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Bearish
4
Neutral
4
Bullish
6
Bearish
36
Neutral
4
Bullish
6
Bearish
32
Neutral
0
Bullish
0
Discovery themes featuring this stock
Royal Sense Limited supplies high-quality goods for hospitals, laboratories, and clinics, offering a broad range of products including surgical accessories, medical equipment, and pharmaceuticals.
Originally a group of sole proprietorships, Royal Sense was incorporated as a Public Limited Company in April 2023, consolidating its existing business under a new corporate structure.
The business has evolved from being a sole proprietorship since 2015, gradually expanding into different product lines and establishing a wide distribution network.
Royal Sense aims to be a comprehensive solution provider for medical and laboratory needs, showcasing a strong alignment with healthcare infrastructure demands.
The company plans to issue 14,50,000 equity shares to the public, which could support further expansion or operational improvements.
Trading
Trading - Medium / Small
90 Cr
High Risk
13.9
37.7
0.0
2.9
309.75
153.00
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
6.79 | 91 Cr | -135.80 | 2.07 | 0.00 | -2.01 | -1.89 | -1.37 | |
4.87 | 91 Cr | 34.79 | 2.54 | 0.00 | 4.42 | 9.08 | 2.64 | |
165.00 | 90 Cr | 13.95 | 2.87 | 0.00 | 22.63 | 27.31 | 15.57 | |
100.00 | 90 Cr | 8.58 | 1.60 | 0.00 | 0.00 | 0.00 | 4.88 | |
82.01 | 89 Cr | 9.04 | 2.07 | 0.00 | 12.91 | 13.90 | 4.23 | |
0.74 | 89 Cr | 1.81 | 0.74 | 0.00 | 2.81 | 2.63 | 4.07 | |
345.00 | 88 Cr | -7.90 | 0.00 | 0.00 | 4.75 | -2.30 | -6.27 |
Royal Sense Ltd (ROYAL) is currently trading at 165.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Royal Sense Limited supplies high-quality goods for hospitals, laboratories, and clinics, offering a broad range of products including surgical accessories, medical equipment, and pharmaceuticals. Originally a group of sole proprietorships, Royal Sense was incorporated as a Public Limited Company in April 2023, consolidating its existing business under a new corporate structure. The business has evolved from being a sole proprietorship since 2015, gradually expanding into different product lines and establishing a wide distribution network. Royal Sense aims to be a comprehensive solution provider for medical and laboratory needs, showcasing a strong alignment with healthcare infrastructure demands. The company plans to issue 14,50,000 equity shares to the public, which could support further expansion or operational improvements.
Over the past 52 weeks, Royal Sense Ltd has traded between a low of ₹153.00 and a high of ₹309.75. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Royal Sense Ltd has a market capitalization of approximately 89.88. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Royal Sense Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 13.95 and operates in the Trading sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 89.88 Cr, Royal Sense Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Royal Sense Ltd operates in the Trading sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Royal Sense Ltd is 13.95. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Change in KMP
Royal Sense Ltd. informed BSE that Ms. Ragini Maurya (ACS:73697) has resigned as Company Secretary & Compliance Officer for personal reasons, relieved effective close of business on 28-Feb-2026; resignation accepted by the Board.
Change in Directors/KMP
Royal Sense Ltd informed BSE that Ms. Ragini Maurya (ACS:73697) resigned as Company Secretary & Compliance Officer effective close of business on 28‑Feb‑2026 for personal reasons; resignation accepted and she was relieved.
